We have a lot of conversations about CBD and cannabis and these have increased since NICE started looking into it. The culture around it is changing as well to make it easier to talk about it in terms that accept that it may have medical benefits and we should at least be looking at this.

But there are a lot of claims and suppliers that are promising the moon when there is a lack of evidence and people are trying to take advantage of the current lack of regulation within CBD oil.

So it is positive to see articles like the one below from Harvard University that try to give a reasoned view of the current status and although it is American in its view there is a lot of information here that is relevant within the UK.

FMA UK supports the calls amongst other pain / health charities that there is a need for more research that establishes not only efficacy but safety and other drug interactions.

To read the article, click here.